secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acutus Medical, Inc. (—)
CIK:        0001522860
Form:       8-K
Filed at:   2024-05-09T23:59:59+00:00
Accession:  0001628280-24-022197
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acutus Medical Q1 revenue up 192% to $3.6M; net loss narrows; stock delisted to OTC Pink
--------------------------------------------------------------------------------

- Q1 continuing ops revenue $3.6M, up 192% YoY; GAAP gross margin improved to -1% from -70%.
- Net loss from continuing ops $2.1M ($0.07/share) vs $4.3M ($0.15) in Q1 2023.
- Cash, equivalents, marketable securities, restricted cash $20.0M at March 31, 2024.
- Nasdaq commenced delisting; stock now trades on OTC Pink under AFIB as of May 9, 2024.
- Company will cease providing financial guidance due to restructuring and exit from EP mapping/ablation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1522860/000162828024022197/0001628280-24-022197-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1522860/000162828024022197/afib-20240509.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-022197

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer